GlaxoSmithKline To Pay $14M In Paxil Antitrust Case
U.K. drug maker GlaxoSmithKline will pay $14 million to settle charges the company violated antitrust laws by seeking to block generic competition for blockbuster antidepressant Paxil by manipulating the patent system....To view the full article, register now.
Already a subscriber? Click here to view full article